Skip to content

Improving cognitive functioning in Parkinson*s disease with transcranial Direct Current Stimulation (PD-tDCS)

Improving cognitive functioning in Parkinson*s disease with transcranial Direct Current Stimulation (PD-tDCS) - PD-tDCS

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42486
Enrollment
120
Registered
2015-11-03
Start date
2015-09-01
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitieve stoornissen Parkinson's Disease-related mild cognitive impairment (PD-MCI)

Interventions

Bipolar tDCS will be administered using two saline-soaked surface sponge electrodes (area 7 x 5 cm2) and delivered by a battery-driven, constant-current stimulator. For atDCS, the anode will be pla

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Clinical diagnosis of PD according to the UK PD Brain Bank criteria60 2) PD-related mild cognitive impairment (PD-MCI) 3) If applicable, stable maintenance of their medication, including dopaminergic treatment, for at least 30 days prior to enrollment and throughout the study.;For the collection on data on instrumental activities of daily living 4) Presence of an informal informant 5) Ability of the informant to complete the questionnaire.

Exclusion criteria

Exclusion criteria: 1) Insufficient mastery of the Dutch language 2) Inability to understand test instructions in Dutch language 3) Any contra indications to tDCS like metallic implants (pacemaker etc.) 4) History of seizures 5) Substance abuse 6) Dementia 7) Major head trauma 8) Bipolar or psychiatric disorder 9) Signs of depression (Hospital Anxiety and Depression Scale, sub score D >7)

Design outcomes

Primary

MeasureTime frame
Efficacy of atDCS in the improvement of executive functioning in PD-MCI.

Secondary

MeasureTime frame
Network connectivity as a predictor and monitor of treatment response Instrumental activities of daily living Motor symptoms Pain perception Health-related quality of life Mood

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)